Location: Home
  • search
  • go
  • Relate News
  • 5/19/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...
  • 5/19/2020Innovent and MD Anderson Announce Partnership to Develop anti-PD-1 The...
  • 5/19/2020Qingdao Primedicine and Primary Peptides Enter Exclusive China Partner...
  • 5/18/2020GSK Granted Clinical Trial Approval of ICOS mAb with Keytruda for HNSC...
  • 5/15/2020Recent Executive Moves
  • 5/15/2020Kangmei Pharma Fined $84,600 for $12.6B Fraud
  • 5/14/2020Consumption Patterns of Chinese Public Medical Institution Drug Sales ...
  • 5/14/2020Snapshot of BMI System Financial Performance in Q1/2020
  • 5/14/2020China's Role in The Global Biotechnology Sector and Implications for U...
  • 5/14/2020Novocure's Optune Approved for Glioblastoma in China
  • 5/14/2020Innovent/Eli Lilly Announce Positive Outcome of TYVYT (Sintilimab Inj)...
  • 5/14/2020Leading Performance Review of Chinese CRO and CDMO/CMO Sector in 2019
  • 5/14/2020Takeda's ADC Drug Adcetris Approved for Marketing in China
  • 5/13/2020CDE Solicits Comments on Draft Guideline on Adaptive Designs for Clini...
  • 5/13/2020CDE Issues Notice on Adjustment of the Submission Time and Form of Imp...
  • 5/12/2020NHSA Issues Notice Requiring BMI Agencies to Settle with Designated Pr...
  • 5/12/2020Herbalmax to Invest $150M in Biotech Project in Wuxi
  • 5/11/2020Simcere Pharma and Primary Peptides Inc. Announce Exclusive China Part...
  • 5/11/2020Novartis Granted Chinese Approval for Multiple Sclerosis Treatment May...
  • 5/11/2020312 A Share-Listed Chinese MedPharm Cos Report 2019 and Q1/2020 Perfor...
  • 5/8/2020CDE Solicits Comments on the Technical Guidelines for Testing of MRD i...
  • 5/8/2020CDE Issues the Technical Guidelines for Study of TSNA Impurities in Ch...
  • 5/8/2020Recent Executive Moves
  • 5/8/2020Junshi Bio Announces Chinese sNDA for Toripalimab in Urothelial Carcin...
  • 5/7/2020Antengene Announces Expansion of Partnership with Karyopharm in Asia P...
  • 5/6/2020Zai Lab's NDA for Omadacycline Granted Priority Review by the CDE
  • 5/6/2020Korean Companies Hope to Win BTX Approvals in China This Year
  • 5/5/2020Uni-Bio and Ypsomed to Co-develop 2nd Generation Diabetes and Osteopor...
  • 5/5/2020Sales Expenditures of Listed Chinese Pharma Cos Up 11% in 2019
  • 5/5/2020Ascentage's HQP1351 Granted Orphan Drug Designation by the USFDA
  • Page:120/360 Total number of articles:10791: [First][<<] [118] [119] [120] [121] [122] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group